COVID-19's impact voluntary sales: Part 3

September 14, 2021 at 09:35 AM
Share & Print

More From HR Executive

NOT FOR REPRINT

© Arc, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.

Related Stories

Self-pay GLP-1 options challenge how employers define drug benefits Supplemental health benefits boost employee retention Biosimilars can help employers get autoimmune drug costs under control Scammers are stealing agents' credentials to commit ACA fraud CBO prepares Congress for new small employer health fight Beware of duplicate pharmacy benefits therapy